PEDIATRICS
XIMENOV 100 D/S

XIMENOV 100 D/S

CEFIXIME 100 MG DRY SYRUPS

MRPโ‚น72.57/-
Packaging30ML
Form TypePAEDIATRIC

CEFIXIME 100 MG DRY SYRUP

Welcome to a universe of drugs, where accuracy, simplicity and uniformity are all in one place. Cefixime 100 MG Dry Syrup, the laboratory-built beverage for you, is here to sweep you off your feet. This ready-made formula is not as easy to use, being a ready-made dilute tablet syrup; it's robust and dry like a powder, which when diluted into a liquid at a specific potency of 100 MG per tablet, it turns into powder.

Our formulation is built with Cefixime, in conjunction with pharmaceutical excipients that have been co-developed. The role of these excipients is often underrated but they are the real 'game changers' for issues such as powder flow, taste, viscosity upon reconstitution and stability for extended periods. The excipients are chosen in conjunction with the product design and specifications.

A perfect inclusion for the PCD Pharma Franchise is Cefixime 100 MG Dry Syrup For newbies entering into the PCD Pharma Franchise existence Cefixime 100 MG Dry Syrup. It's important to keep-up with the quality of powders, filling accuracy, quality of reconstitution and packaging to benefit the uniform value of the product in each batch.

POWDER CHARACTERISTICS AND MOISTURE MANAGEMENT

The powder properties define the dry syrup at its core. While, the particle size, bulk density and flowability of Cefixime and excipients are parameters of quality, controlling moisture, which can otherwise severely affect powder flow, product stability as well as its reconstitution properties, becomes extremely important, and lives in the production environment.

Depending on formulation design, ingredients may be sieved, dry blended, or granulated. Process steps are selected to produce a free flowing powder for filling into containers. For low dose or well dispersed powder formulation ingredients are preblended with gentle mixing to optimize powder homogeneity and reduces segregation by ingredient addition order and mixing time.

Bulk density and powder flow are important considerations during filling. Differences can lead to differences in fill-weight, but with proper in-process controls, all containers will be uniformly filled.

RECONSTITUTION AND SUSPENSION PERFORMANCE

When the powder gets immersed in water, it should compose into a homogenous solution of the specified attributes.

The development studies examine the wetting, dispersion, sedimentation, and redispersion of the system. These parameters will determine the liquid or suspension consistency after the addition of water.

The final viscosity must be appropriate-not too thick, not too thin-for the reconstituted product to be easy to stir and measure. In the event that the reconstituted product is a suspension, it should be highly dispersible.

Particle-size distribution influences the speed and uniformity of reconstitution. Larger, more agglomerated particles will influence the nature of the liquid and it is important to process the powder under controlled conditions so that performance is consistent.

Flavoring and sweetening ingredients (if used) should also be evenly distributed throughout the dry mix, their concentration and compatibility optimized during the formulation process.

MANUFACTURING AND QUALITY-CONTROL PARAMETERS

Cefixime 100 MG Dry Syrup Manufacturing Making Cefixime 100 MG Dry Syrup Manufacturing is a complex process. It starts with the inspection and weighing of Cefixime and other components. The raw materials pass through a specified order with moisture and powder flow state, while..

Blending is an art, which must be performed under defined conditions in order to obtain a uniformly mixed powder. If there is granulation, then the granules are dried, sized and measured before they are blended.

In-process testing involves tests on moisture content, bulk density, powder flow and blend uniformity. The controls are the guardians overseeing the control of the manufacturing process by bringing it within the specified parameters.

Finished-product testing should characterize the Finished-product containing the Cefixime, including; Identification and assay test โ€“ the finished-product should be tested for the identity of the Cefixime along with assay test; Content uniformity; Moisture; Reconstitution; pH; Viscosity and Microbial testing. The analytical techniques should be validated and provide quantitative and reliable data. If the pharmacopoeia standards are applicable; the test is carried out in accordance with the said standards.

Batch documentation is essential. It records raw-material information, batch sizes, processing parameters, equipment used, observations, analytical findings, and packing records that can be traced and recreated for each batch.

PACKAGING, STABILITY, AND PCD PHARMA PRODUCT DEVELOPMENT

Packaging is not just packing โ€“ it's protection. As dry syrup, it protects the product from external humidity prior to reconstitution. Glass bottles designed for pharmaceutical applications with secure caps are selected for the specifications of the product.

Protection from moisture. The container-closure system shall provide a barrier to moisture and be resistant to moisture transmission through and from the closure system during storage. The fill volume, headspace, the fit of the closure and the label dimensions are monitored during packaging.

Stability testing evaluates the characteristics of the dry powder throughout the storage period such as appearance, assay, moisture, microbial quality. Reconstituted-product stability studies are performed under approved storage conditions and for use.

Packaging should allow the addition of water but also offer protection. Pack formation and bottle size and fill level are taken into account in pack development.

Cefixime 100 MG Dry Syrup Quality GMP Pharma Franchise Standardized Manufacturing

Cefixime 100 MG Dry Syrup assures its consumers of its unique presentation as well as its product making processes like moist humidity protection and documented quality procedures. The uniformity of the powder characteristics and the reconstitution behavior is guaranteed.

To conclude, the processes of producing Cefixime 100 MG Dry Syrup require a careful balance of all controlled specifications -Quality of Active-Ingredient, Powder Flow, Moisture Levels, Mixing Homogeneity, Filling Accuracy, Reconstitution Behavior, Viscosity, Microbial Quality, Compatibility of the packaging, and Stability. Achieve all of these specifications in a dry oral dosage form meant to be developed by professional Pharmaceutics.

Cefixime 100 MG Dry Syrup with focus on formulation, reconstitution, manufacturing, quality control, moisture protection, packaging and stability.

Send Your Enquiry Now!

Inquire Now

Our Expertise in Pharma Industry

We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.

Product Quality
98%
Customer Satisfaction
95%
On-Time Delivery
97%
Market Growth Support
93%
Product Range Availability
96%
Business Success Rate
92%